Resiliency in Patients Undergoing Radical Cystectomy for Bladder Cancer - Trial NCT06337305
Access comprehensive clinical trial information for NCT06337305 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Kansas Medical Center and is currently Completed. The study focuses on Bladder Cancer. Target enrollment is 74 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
University of Kansas Medical Center
Timeline & Enrollment
N/A
Aug 19, 2020
Aug 19, 2023
Primary Outcome
Change in resiliency as measured by the Connor-Davidson Resilience Scale (CD-RISC-25).,Change in quality of life in patients undergoing radical cystectomy as measured by the Functional Assessment of Cancer Therapy-Bladder-Cystectomy (FACT-Bl-Cys).,Change in quality of life in patients undergoing radical cystectomy as measured by the PROMIS-29.
Summary
This is a prospective cross-sectional survey-based study composed of both a retrospective
 chart review and 3-series patient survey. This study will help elicit potential areas
 throughout the perioperative course of radical cystectomy to improve patient resilience and
 quality of life, providing opportunity for future interventional studies.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06337305
Non-Device Trial